Tea planter Vishal Mahindra was twice diagnosed with non-Hodgkin's lymphoma, a type of blood cancer that develops in the ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Skin (cutaneous) lymphomas often manifest as a skin rash. Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma ...

Approval follows results from the Phase III ECHO trial, which demonstrated that Calquence plus chemotherapy reduced the risk ...

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

Neelapu sat down with CURE® to discuss the phase 2 ZUMA-5 trial which evaluated the CAR-T cell therapy Yescarta (axicabtagene ciloleucel) in patients with relapsed/refractory indolent non-Hodgkin ...

Skin (cutaneous) lymphomas often manifest as a skin rash. Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) ...

Marginal zone lymphoma is a rare type of blood cancer, making up about 7% of non-Hodgkin lymphomas ... the most common adverse effects were photosensitivity and skin rash and elevated liver enzyme ...

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...